Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
50%(2 trials)

Phase Distribution

Ph phase_2
1
20%
Ph not_applicable
3
60%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(4)

Detailed Status

Completed4
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (25.0%)
N/A3 (75.0%)

Trials by Status

not_yet_recruiting120%
completed480%

Recent Activity

0 active trials
Showing 5 of 5
not_yet_recruitingphase_2

Evaluating the Efficacy of the Combination of Multi-zonal Contact Lens and Atropine for Controlling Myopia Progression

NCT06765603
completednot_applicable

Evaluating Contact Lens Optics

NCT05028790
completednot_applicable

Contact Lens Optics and Visual Performance

NCT05308069
completednot_applicable

Accommodative Relief for Uncomfortable Non-Presbyopes

NCT03544216
completed

Evaluation of Visual Performance With Contact Lenses

NCT03705130

Clinical Trials (5)

Showing 5 of 5 trials
NCT06765603Phase 2

Evaluating the Efficacy of the Combination of Multi-zonal Contact Lens and Atropine for Controlling Myopia Progression

Not Yet Recruiting
NCT05028790Not Applicable

Evaluating Contact Lens Optics

Completed
NCT05308069Not Applicable

Contact Lens Optics and Visual Performance

Completed
NCT03544216Not Applicable

Accommodative Relief for Uncomfortable Non-Presbyopes

Completed
NCT03705130

Evaluation of Visual Performance With Contact Lenses

Completed

All 5 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
5